Last €17.45 EUR
Change Today -0.028 / -0.16%
Volume 385.0
AB3A On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 9:30 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sandesh Mahatme

Chief Financial Officer, Chief Accounting Officer and Senior Vice President, Sarepta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

48$4,836,954
As of Fiscal Year 2012

Background*

Mr. Sandesh Mahatme, also known as Sandy, has been the Chief Financial Officer and Senior Vice President at Sarepta Therapeutics, Inc. since November 5, 2012 and Chief Accounting Officer since October 4, 2013. Prior to Sarepta, Mr. Mahatme served in various roles including Senior Vice President of Corporate Development, Corporate Treasurer and Senior Vice President of Tax at Celgene Corporation since 2006. While at Celgene, he was instrumental in building Celgene's Treasury ...

Read Full Background

Corporate Headquarters*

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 857-242-3700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Master's Degree
Cornell University School of Law
Master's Degree
New York University School Of Law

Other Affiliations*

Annual Compensation*

Salary$67,836
Bonus$130,000
Total Annual Compensation$197,836

Stock Options*

All Other Compensation$598
Unexercisable Options250,000
Unexercisable Options Value$487,500
Total Value of Options$487,500
Total Number of Options250,000

Total Compensation*

Total Annual Cash Compensation$236,004
Total Short Term Compensation$197,836
Other Long Term Compensation$598
Total Calculated Compensation$4,836,954
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AB3A:GR €17.45 EUR -0.028

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
William A. Carter M.D.Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee
Hemispherx Biopharma, Inc.
$1.0M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Friedhelm Blobel Ph.D.Chief Executive Officer, President and Executive Director
SciClone Pharmaceuticals, Inc.
$500.0K
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.